Annual EBIT
-$3.04 M
-$858.20 K-39.36%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual earnings before interest & taxes is currently -$3.04 million, with the most recent change of -$858.20 thousand (-39.36%) on 31 December 2023. During the last 3 years, it has fallen by -$1.71 million (-128.91%). GDTC annual EBIT is now -128.91% below its all-time high of -$1.12 million.GDTC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.4% | - | - |
| 3 y3 years | -128.9% | - | - |
| 5 y5 years | - | - | - |
GDTC EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -128.9% | at low | ||||
| 5 y | 5 years | -128.9% | at low | ||||
| alltime | all time | -128.9% | at low |
CytoMed Therapeutics Limited EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$3.04 M(+39.4%) | - | - |
| Dec 2022 | -$2.18 M(+51.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.44 M(+8.4%) | - | - |
| Dec 2020 | -$1.33 M | - | - |
FAQ
- What is CytoMed Therapeutics Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual EBIT year-on-year change?
What is CytoMed Therapeutics Limited annual earnings before interest & taxes?
The current annual EBIT of GDTC is -$3.04 M
What is the all time high annual EBIT for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual earnings before interest & taxes is -$1.12 M
What is CytoMed Therapeutics Limited annual EBIT year-on-year change?
Over the past year, GDTC annual earnings before interest & taxes has changed by -$858.20 K (-39.36%)